Search
for
Sort by
Research 30 of 108
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- Sunitinib
- 710 BIOMARKERS OF SUNITNIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA PATIENTS
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- Efluvio anágeno. Hallazgos tricoscópicos
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The PDGF/PDGFR pathway as a drug target
- Drug-Induced Skin, Nail and Hair Disorders
- Adverse effects of common medications on male fertility
- Anagen effluvium
- Drug-induced acne
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- An Update on Drug-Induced Pigmentation
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Drug eruptions in dermatology